Yale SPORE in Lung Cancer Developmental Research Program
Yale SPORE in Lung Cancer Developmental Research Program
批准号:
10203857
负责人:
Roy S Herbst
金额:
$8.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-08-26 至 2025-07-31
关键词:
AgreementAreaAwardBiologyBudgetsCaliberCancer BiologyCarcinogenesis MechanismClinicalCollaborationsCommittee MembersCommunitiesConsultationsDevelopmentDirect CostsElectronic MailEnsureFinancial SupportFosteringFundingFunding MechanismsFutureGoalsGuidelinesHumanInstitutionLeadershipMalignant NeoplasmsMalignant neoplasm of lungMethodsMonitorMorbidity - disease rateOutcomePilot ProjectsPrediction of Response to TherapyProcessProductivityPrognosisProgram Research Project GrantsRecruitment ActivityResearchResearch PersonnelResearch Project GrantsResource SharingRisk AssessmentStudy SectionTranslationsUnited States National Institutes of HealthWomanWorkYale Cancer Centeranticancer researchcancer therapyearly detection biomarkersinnovationmeetingsmemberminority investigatormortalitynew therapeutic targetnovelnovel therapeuticspersonalized medicineprogramsrecruittranslational research programtumorigenesis
中文摘要
节目概要
耶鲁大学肺癌研究中心(YSILC)发展研究项目(DRP)的主要目标
确定并资助具有转化潜力的创新试点项目,
风险评估领域的肺癌领域;早期检测;预后、治疗和治疗的生物标志物
预测;生物学;和新的治疗方法。受资助的发展研究和项目
强烈鼓励研究项目与耶鲁内外的其他研究人员合作,
包括其他SPORE研究社区,目标是这些项目将发展成为独立的完整的
SPORE项目或同等规模的研究。YSILC DRP的目标是开发创新肺
癌症转化研究项目。为实现这一目标,我们提出以下三个具体目标:
具体目标1。确定和招募具有肺癌转化潜力的创新试点项目。
具体目标2。通过资助创新试点项目,支持肺癌的新研究机会。
具体目标3。加强SPORE完整研究项目与DRP研究人员之间的合作
(当前和潜在),并将DRP项目推广为潜在的完整SPORE或同等规模的项目。
大力鼓励由减少灾害风险方案机制资助的试点项目与区域内和区域间机构合作,
孢子项目。在下列情况下,取得重大进展的项目将被考虑纳入一个完整的项目
有任何方案需要,并在YSILC领导与
内部顾问委员会、外部顾问委员会和NCI工作人员。
英文摘要
PROGRAM SUMMARY
The primary goal of the Developmental Research Program (DRP) of the Yale SPORE in Lung Cancer (YSILC)
is to identify and fund innovative pilot projects that possess translational potential for making an impact in the
field of lung cancer in the areas of risk assessment; early detection; biomarkers for prognosis, therapy, and
prediction; biology; and novel treatment approaches. Investigators and projects of funded developmental
research projects are strongly encouraged to collaborate with other investigators within and outside of Yale,
including other SPORE research communities, with the goal that these projects will evolve into independent full
SPORE projects or equivalent scale studies. The objective of the YSILC DRP is to develop innovative lung
cancer translational research programs. To achieve this goal, we propose the following three specific aims:
Specific Aim 1. To identify and recruit innovative pilot projects with translational potential for lung cancer.
Specific Aim 2. To support new research opportunities for lung cancer by funding innovative pilot projects.
Specific Aim 3. To enhance collaborations between SPORE full research projects and DRP investigators
(current and potential) and to promote DRP projects to potential full SPORE or equivalent scale projects.
Pilot projects funded by the DRP mechanism are strongly encouraged to collaborate with intra- and inter-
SPORE projects. Projects making significant progress will be considered for incorporation into a full project if
there are any programmatic needs and upon agreement of the YSILC leadership in consultation with the
Internal Advisory Board, External Advisory Board and NCI staff.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Yale Cancer Center NCTN LAPS
-
批准号:10359158
-
项目类别:
-
资助金额:$48.49万
-
财政年份:2019
-
负责人:Roy S Herbst
-
依托单位:
Yale Cancer Center NCTN LAPS
-
批准号:10582614
-
项目类别:
-
资助金额:$87.91万
-
财政年份:2019
-
负责人:Roy S Herbst
-
依托单位:
Yale Cancer Center NCTN LAPS
-
批准号:10734497
-
项目类别:
-
资助金额:$12.0万
-
财政年份:2019
-
负责人:Roy S Herbst
-
依托单位:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
-
批准号:10203850
-
项目类别:
-
资助金额:$200.37万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
-
批准号:9767058
-
项目类别:
-
资助金额:$213.48万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
-
批准号:9338869
-
项目类别:
-
资助金额:$71.51万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
-
批准号:8931829
-
项目类别:
-
资助金额:$218.5万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Core A: Administrative Core
-
批准号:10203851
-
项目类别:
-
资助金额:$15.48万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Administrative Core
-
批准号:8931832
-
项目类别:
-
资助金额:$86.07万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
MicroRNA-based interventions to prevent progression from lung preneoplasia to adenocarcinoma
-
批准号:9379210
-
项目类别:
-
资助金额:$20.76万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways
-
批准号:8920514
-
项目类别:
-
资助金额:$55.45万
-
财政年份:2011
-
负责人:Roy S Herbst
-
依托单位:
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways
-
批准号:8707401
-
项目类别:
-
资助金额:$54.12万
-
财政年份:2011
-
负责人:Roy S Herbst
-
依托单位:
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways
-
批准号:8517039
-
项目类别:
-
资助金额:$52.79万
-
财政年份:2011
-
负责人:Roy S Herbst
-
依托单位:
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways
-
批准号:8332772
-
项目类别:
-
资助金额:$56.49万
-
财政年份:2011
-
负责人:Roy S Herbst
-
依托单位:
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways
-
批准号:8186504
-
项目类别:
-
资助金额:$58.43万
-
财政年份:2011
-
负责人:Roy S Herbst
-
依托单位:
U10 Ful Member Application Affiliated with SWOG
-
批准号:7555078
-
项目类别:
-
资助金额:$21.59万
-
财政年份:2004
-
负责人:Roy S Herbst
-
依托单位:
U10 Full Member Application Affiliated with SWOG
-
批准号:7767468
-
项目类别:
-
资助金额:$32.57万
-
财政年份:2004
-
负责人:Roy S Herbst
-
依托单位:
Phase I trial of antiangiogenic agent SU6668 in Pt w solid tumors
-
批准号:6563965
-
项目类别:
-
资助金额:$29.68万
-
财政年份:2002
-
负责人:Roy S Herbst
-
依托单位:
Core--Clinical trials
-
批准号:6563968
-
项目类别:
-
资助金额:$29.68万
-
财政年份:2002
-
负责人:Roy S Herbst
-
依托单位:
Core--Clinical trials
-
批准号:6499818
-
项目类别:
-
资助金额:$29.68万
-
财政年份:2001
-
负责人:Roy S Herbst
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: